Literature DB >> 20582973

Cyclic neutropenia and severe congenital neutropenia in patients with a shared ELANE mutation and paternal haplotype: evidence for phenotype determination by modifying genes.

Peter E Newburger1, Talia N Pindyck, Zhiqing Zhu, Audrey Anna Bolyard, Andrew A G Aprikyan, David C Dale, Gary D Smith, Laurence A Boxer.   

Abstract

BACKGROUND: Cyclic neutropenia (CN) and severe congenital neutropenia (SCN) are disorders of neutrophil production that differ markedly in disease severity. Mutations of the ELANE gene (the symbol recently replacing ELA2) are considered largely responsible for most cases of CN and SCN, but specific mutations are typically associated with one or the other. PROCEDURE: We performed ELANE genotyping on all individuals and paternal sperm in an SCN kindred with eight SCN progeny of a sperm donor and six different mothers.
RESULTS: One patient with CN had the same S97L ELANE mutation as seven patients with the SCN phenotype. The mutant allele was detected in the donor's spermatozoa, representing 18% of the ELANE gene pool, but not in DNA from his lymphocytes, neutrophils, or buccal mucosa, indicating gonadal mosaicism.
CONCLUSIONS: The coexistence of CN and SCN phenotypes in this kindred with a shared paternal haplotype strongly suggests both a role for modifying genes in determination of congenital neutropenia disease phenotypes, and the classification of CN and SCN within a spectrum of phenotypes expressing varying degrees of the same disease process. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20582973      PMCID: PMC2913300          DOI: 10.1002/pbc.22537

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  27 in total

1.  Impaired survival of bone marrow hematopoietic progenitor cells in cyclic neutropenia.

Authors:  A A Aprikyan; W C Liles; E Rodger; M Jonas; E Y Chi; D C Dale
Journal:  Blood       Date:  2001-01-01       Impact factor: 22.113

2.  Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis.

Authors:  M Horwitz; K F Benson; R E Person; A G Aprikyan; D C Dale
Journal:  Nat Genet       Date:  1999-12       Impact factor: 38.330

Review 3.  Cyclic neutropenia.

Authors:  David C Dale; Audrey Anna Bolyard; Andrew Aprikyan
Journal:  Semin Hematol       Date:  2002-04       Impact factor: 3.851

4.  Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia.

Authors:  D C Dale; R E Person; A A Bolyard; A G Aprikyan; C Bos; M A Bonilla; L A Boxer; G Kannourakis; C Zeidler; K Welte; K F Benson; M Horwitz
Journal:  Blood       Date:  2000-10-01       Impact factor: 22.113

5.  Mutations in the ELA2 gene encoding neutrophil elastase are present in most patients with sporadic severe congenital neutropenia but only in some patients with the familial form of the disease.

Authors:  P J Ancliff; R E Gale; R Liesner; I M Hann; D C Linch
Journal:  Blood       Date:  2001-11-01       Impact factor: 22.113

6.  Neutrophil elastase is severely down-regulated in severe congenital neutropenia independent of ELA2 or HAX1 mutations but dependent on LEF-1.

Authors:  Julia Skokowa; John Paul Fobiwe; Lan Dan; Basant Kumar Thakur; Karl Welte
Journal:  Blood       Date:  2009-07-20       Impact factor: 22.113

7.  Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2.

Authors:  Richard E Person; Feng-Qian Li; Zhijun Duan; Kathleen F Benson; Jeremy Wechsler; Helen A Papadaki; George Eliopoulos; Christina Kaufman; Salvatore J Bertolone; Betty Nakamoto; Thalia Papayannopoulou; H Leighton Grimes; Marshall Horwitz
Journal:  Nat Genet       Date:  2003-07       Impact factor: 38.330

Review 8.  The role of apoptosis in the pathophysiology of chronic neutropenias associated with bone marrow failure.

Authors:  Helen A Papadaki; George D Eliopoulos
Journal:  Cell Cycle       Date:  2003 Sep-Oct       Impact factor: 4.534

9.  Cellular and molecular abnormalities in severe congenital neutropenia predisposing to leukemia.

Authors:  Andrew A G Aprikyan; Tatyana Kutyavin; Steven Stein; Pavel Aprikian; Elin Rodger; W Conrad Liles; Laurence A Boxer; David C Dale
Journal:  Exp Hematol       Date:  2003-05       Impact factor: 3.084

10.  Mutations in the ELA2 gene correlate with more severe expression of neutropenia: a study of 81 patients from the French Neutropenia Register.

Authors:  Christine Bellanné-Chantelot; Séverine Clauin; Thierry Leblanc; Bruno Cassinat; Fernando Rodrigues-Lima; Sandrine Beaufils; Christelle Vaury; Mohamed Barkaoui; Odile Fenneteau; Micheline Maier-Redelsperger; Christine Chomienne; Jean Donadieu
Journal:  Blood       Date:  2004-02-12       Impact factor: 22.113

View more
  19 in total

1.  Novel ELANE Gene Mutation in a Newborn with Severe Congenital Neutropenia: Case Report and Literature Review.

Authors:  Yue Jia; Changjun Yue; Kathryn Bradford; Xin Qing; Eduard H Panosyan; Moran Gotesman
Journal:  J Pediatr Genet       Date:  2019-11-18

Review 2.  Neutropenia in the newborn.

Authors:  Akhil Maheshwari
Journal:  Curr Opin Hematol       Date:  2014-01       Impact factor: 3.284

Review 3.  Severe congenital neutropenias.

Authors:  Julia Skokowa; David C Dale; Ivo P Touw; Cornelia Zeidler; Karl Welte
Journal:  Nat Rev Dis Primers       Date:  2017-06-08       Impact factor: 52.329

4.  Mosaicism of an ELANE Mutation in an Asymptomatic Mother.

Authors:  Tomonari Shigemura; Norimoto Kobayashi; Kazunaga Agematsu; Osamu Ohara; Yozo Nakazawa
Journal:  J Clin Immunol       Date:  2019-01-12       Impact factor: 8.317

5.  Description of an ELANE Mutation in a Girl with Severe Congenital Neutropenia: A Paradigm of Targeted Genetic Screening Based on Clinical Findings.

Authors:  Maria Gogou; Labrini Damianidou; Theodotis Papageorgiou; Athanasios Tragiannidis; Katerina Haidopoulou; Andreas Giannopoulos; Emmanuel Hatzipantelis
Journal:  J Pediatr Genet       Date:  2018-09-15

Review 6.  Evaluation and management of patients with isolated neutropenia.

Authors:  Peter E Newburger; David C Dale
Journal:  Semin Hematol       Date:  2013-07       Impact factor: 3.851

Review 7.  The diversity of mutations and clinical outcomes for ELANE-associated neutropenia.

Authors:  Vahagn Makaryan; Cornelia Zeidler; Audrey Anna Bolyard; Julia Skokowa; Elin Rodger; Merideth L Kelley; Laurence A Boxer; Mary Ann Bonilla; Peter E Newburger; Akiko Shimamura; Bin Zhu; Philip S Rosenberg; Daniel C Link; Karl Welte; David C Dale
Journal:  Curr Opin Hematol       Date:  2015-01       Impact factor: 3.284

8.  Pathogenesis of ELANE-mutant severe neutropenia revealed by induced pluripotent stem cells.

Authors:  Ramesh C Nayak; Lisa R Trump; Bruce J Aronow; Kasiani Myers; Parinda Mehta; Theodosia Kalfa; Ashley M Wellendorf; C Alexander Valencia; Patrick J Paddison; Marshall S Horwitz; H Leighton Grimes; Carolyn Lutzko; Jose A Cancelas
Journal:  J Clin Invest       Date:  2015-07-20       Impact factor: 14.808

Review 9.  ELANE mutations in cyclic and severe congenital neutropenia: genetics and pathophysiology.

Authors:  Marshall S Horwitz; Seth J Corey; H Leighton Grimes; Timothy Tidwell
Journal:  Hematol Oncol Clin North Am       Date:  2012-11-07       Impact factor: 3.722

10.  A novel homozygous mutation in G6PC3 presenting as cyclic neutropenia and severe congenital neutropenia in the same family.

Authors:  Abdullah A Alangari; Abdulrahman Alsultan; Mohamed Elfaki Osman; Shamsa Anazi; Fowzan S Alkuraya
Journal:  J Clin Immunol       Date:  2013-10-09       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.